Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma.
Hideshima T, Qi J, Paranal RM, Tang W, Greenberg E, West N, Colling ME, Estiu G, Mazitschek R, Perry JA, Ohguchi H, Cottini F, Mimura N, Görgün G, Tai YT, Richardson PG, Carrasco RD, Wiest O, Schreiber SL, Anderson KC, Bradner JE. Hideshima T, et al. Among authors: richardson pg. Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13162-13167. doi: 10.1073/pnas.1608067113. Epub 2016 Oct 31. Proc Natl Acad Sci U S A. 2016. PMID: 27799547 Free PMC article.
Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Libermann TA, Treon SP, Munshi NC, Richardson PG, Hideshima T, Anderson KC. Mitsiades N, et al. Among authors: richardson pg. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14374-9. doi: 10.1073/pnas.202445099. Epub 2002 Oct 21. Proc Natl Acad Sci U S A. 2002. PMID: 12391322 Free PMC article.
Proteasome inhibition in the treatment of cancer.
Richardson PG, Mitsiades C, Hideshima T, Anderson KC. Richardson PG, et al. Cell Cycle. 2005 Feb;4(2):290-6. Epub 2005 Feb 3. Cell Cycle. 2005. PMID: 15655370 Review.
Proteasome inhibitors as therapeutics.
Mitsiades CS, Mitsiades N, Hideshima T, Richardson PG, Anderson KC. Mitsiades CS, et al. Among authors: richardson pg. Essays Biochem. 2005;41:205-18. doi: 10.1042/EB0410205. Essays Biochem. 2005. PMID: 16250907 Review.
Current therapeutic uses of lenalidomide in multiple myeloma.
Hideshima T, Richardson PG, Anderson KC. Hideshima T, et al. Among authors: richardson pg. Expert Opin Investig Drugs. 2006 Feb;15(2):171-9. doi: 10.1517/13543784.15.2.171. Expert Opin Investig Drugs. 2006. PMID: 16433596 Review.
Lenalidomide in multiple myeloma.
Richardson PG, Mitsiades C, Hideshima T, Anderson KC. Richardson PG, et al. Expert Rev Anticancer Ther. 2006 Aug;6(8):1165-73. doi: 10.1586/14737140.6.8.1165. Expert Rev Anticancer Ther. 2006. PMID: 16925483 Review.
Recent advances in the treatment of Multiple Myeloma.
Yasui H, Hideshima T, Richardson PG, Anderson KC. Yasui H, et al. Among authors: richardson pg. Curr Pharm Biotechnol. 2006 Oct;7(5):381-93. doi: 10.2174/138920106778521569. Curr Pharm Biotechnol. 2006. PMID: 17076653 Review.
562 results